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Many examples of antibody-catalyzed reactions have been reported, ranging from efficient acyl transfer and redox reactions to stereoelectronically disfavored pericyclic and cyclization reactions (1, 2) . In addition to providing a strategy for generating catalysts for reactions difficult to achieve by existing enzymatic or chemical methods, antibody catalysis provides a tool to gain increased insight into the mechanisms of biological catalysis and the evolution of catalytic function. These latter aims are facilitated by the availability of threedimensional structures of antibody active sites, coupled with mutagenesis experiments to confirm hypotheses about reaction mechanisms. Unfortunately, such studies have been hampered by difficulties in expressing many of the antibodies in recombinant form in quantities sufficient for mechanistic and crystallographic studies. In addition, the ability to express antibodies or antibody fragments in a bacterial system in soluble form, either periplasmically or cytoplasmically, is a prerequisite for attempts to improve their catalytic efficiency using random or directed mutagenesis, coupled with in vivo selection techniques (3, 4) .
A number of systems for the production of antibody fragments have been described, most of which use bacterial signal sequences to direct the immunoglobulin chains to the periplasm or culture medium, where correct folding and disulfide bond formation are possible (for review, see ref. 5 ). However, reports of expression systems rarely describe their general applicability. For example, we have examined a variety of published systems by using a number of hybridoma-and myeloma-derived antibodies, including Fab and single-chain Fv fragments, various promoters [T7, lac, tac, and alkaline phosphatase (PhoA)], signal sequences (pelB and stII), fusions to maltose binding protein and ThiA (6) , exchange of the constant (C) regions, and expression as a single-chain Fv fragment in the yeast Pichia pastoris (7) (ref. 8 and H.D.U. and P.G.S., unpublished results). In each case, the majority of the protein was found in insoluble aggregates, suggesting that the primary structure of the antibody greatly influences its correct
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folding in the periplasm and remains the limiting factor for its performance in a given expression system. The extensive study of the antibody McPC603 by Knappik and Pluckthun (9) supports this notion. A number of antibodies have been derived from phage display methods that express well and in soluble form (10) . However, the well-behaved nature of these antibodies is likely a consequence of concurrent selection for correctly folded proteins and may not apply to hybridomaderived antibodies.
One of the earliest reports of the expression of soluble antibody fragments in Escherichia coli was based on a chimeric Fab fragment (11) . Carter and coworkers (12) (13) (14) have observed large increases in expression yields of three humanized Fab fragments over the corresponding murine proteins; where reported, the murine-human chimeric Fab fragment was intermediate (12) . Based on these observations, we have examined the expression of a panel of catalytic antibodies in a system that exploits this beneficial influence of the human sequences on the folding of the Fab fragment in the bacterial periplasm. Herein we report the expression studies of both hybridoma-derived antibodies and artificially constructed combinations of heavy and light chains and report the effects of point mutations and growth conditions on yields. This system appears to be generally applicable for the facile production of useful quantities of active soluble mouse-human chimeric Fab fragments.
MATERIALS AND METHODS
Strains and Plasmids. E. coli JM109 (15) chains with 48G7 were constructed by swapping EcoRIBamHI fragments containing the light chain sequences between pDEI434 and the respective expression vectors. The 48G7 mutants were generated by site-directed mutagenesis in pDEI440 and were expressed directly in this vector.
Expression and Purification of Chimeric Fab Fragments. For small-scale expression, 25 16 ,000 rpm for 10 min in an SS34 rotor) and subjected to another incubation in lysis buffer as before. The supernatants were either subjected to an ammonium sulfate precipitation (80% saturation) or concentrated to 100 ml in an Amicon ultrafiltration cell. Purification on protein G affinity columns (Sepharose CL-6B, Pierce) was performed at room temperature in 50 mM Mes, pH 5.5/100 mM NaCl. Protein was eluted with 100 mM glycine (pH 2.8); and the eluate was neutralized immediately with 0. (8, 18, (22) (23) (24) (25) (26) . Catalytic activity was measured as described (8, (22) (23) (24) 26) . Concentrations of purified antibody were determined by measuring A280 and A260 (28) . Extinction coefficients varied between 61,500 and 74,200 M-1 cm-1.
RESULTS AND DISCUSSION
Vector Construction. To investigate the beneficial influence of the human sequences on the folding of the Fab fragment in the bacterial periplasm, we chose to pursue chimeric constructs as opposed to humanized versions of our catalytic antibodies. Humanization is an involved process that almost inevitably results in some change in affinity for the hapten (29) that would likely be detrimental to catalysis. Due to the independence of V and C domains (30) , no change in the structure of the V domains is observed when the murine C regions are exchanged for human versions (31) .
The expression system is based on that described by Carter et al. (12) and this group (8) . The vector from which it is derived, pMY61, is a pBR322 derivative very similar to pAK19 (12) ; it uses the same PhoA promoter, inducible by phosphate starvation (32), stIl signal sequences for secretion into the periplasm (33) , and human C regions (34, 35) , excluding the Cys-Ala-Ala hinge at the C terminus of the CH1 region. The V regions of the p-nitrophenyl phosphonate-specific antibody 48G7 were subcloned into this vector from pDE166 (8) . The genes of the phosphocholine-specific myeloma S107 (19) and those of the hybridoma 2E11 (18) were derived from analogous constructs, into which they had been previously cloned from the corresponding cell lines (H.D.U., P.A.P., and P.G.S., unpublished results). The vector bearing the 48G7 Fab fragment was then modified to allow the use of the V region PCR primers H1-H1O and L1-L7, described by Huse et al. (17) , to clone antibody genes of unknown sequences: a Sac I site in the CK sequence and a HindlIl site upstream of the promoter were removed, Sac I and Xho I sites were incorporated at the N terminus of VK and VH, respectively, and Hindlll and BstEII sites were introduced into the J region sequences, resulting in the vector p4xH (Fig. 1) .
PCR primers incorporating HindIlI and BstEII sites into JK and JH, respectively, were designed to complement the V region primers. Combinations of these primers were used to amplify the V regions of the antibodies 18R.136.1 (22), 28B4.2 (23), AZ-28 (24), 39,A11.1 (25) , and 7G12-A10 (26) from cDNA obtained from their respective cell lines. The sequences of the light and heavy chain V regions of the cloned hybridomas along with 48G7 and S107 are listed in Fig. 2 Expression yields are given in Table 1 .
With the exception of the myeloma-derived S107, the yields are in the range of 1-3 mg/liter for four antibodies and 0.1-0.3 mg/liter for the remaining three, which compares well with reported values (11) . No obvious correlation between sequence homology and expression level was observed. The Fab fragments retained their hapten-binding and catalytic activity where tested (Table 1) . Importantly, in all antibodies tested, the majority of the protein was produced in soluble form, whereas only a small fraction of Fab was soluble in the systems that we had examined previously. Even the small amounts of S107 Fab fragments were soluble, and only for the 2E11 clone was >10% of total antibody associated with the cytoplasmic fraction (data not shown). Large quantities of recombinant protein could be produced in high-density (70-100 OD580 units) fermentations in a 2.5-liter Bioflow III fermentor by using a modification of the protocol described by Carter et al. (12) . Again, the antibodies were produced in soluble form, associated with the periplasm, and yields (10-150 mg/liter) were sufficient for crystallization and extensive kinetic studies (Table 1) .
On Western blots of crude periplasmic fractions of AZ-28, an additional band below the functional Fab fragment was detected. Deleting the heavy chain sequences from the plasmid and comparing the pattern of expression indicated that the additional band was a disulfide-linked light chain dimer. Deletion of the 48G7 heavy chain sequences resulted in light chains that migrated as monomers on a nonreducing gel (data not shown). The expression levels of these light chains were strongly reduced compared to the complete Fab fragment, indicating that isolated light chains are fairly unstable in the E. +P04, lysate from a culture grown in the presence of 2.0 mM sodium phosphate., coli periplasm. Since the dimers do not bind to the protein G affinity column, they do not present a problem for purification.
Characterization of Chain Combinations. Part of the diversity of the immune response is generated by the random combination of heavy and light chains during B-cell development. Due to this combinatorial diversity, antibody chains are well adapted to associate randomly with each other to form stable pairs. The association derives mainly from the interaction between the C regions (37), but the V regions are promiscuous enough to allow for random pairings. This property is exploited in phage and in vivo expression libraries.
To test whether the chimeric expression system would accommodate pairs of heavy and light chains that were not selected to associate with each other during an immunization process, chain combinations between 48G7 and the other clones were constructed and expressed. In no case was the expression of a hybrid clone worse than that of the poor partner, indicating that the yield depends to a large degree on the expression level of the individual chains and not their association. The combinations also revealed which of the chains was responsible for the varying expression levels observed. For example, the combination of the AZ-28 heavy chain and the 48G7 light chain expressed like AZ-28 itself, whereas the reverse combination showed levels comparable to 48G7, and light chain dimers were no longer observed, indicating that for AZ-28, the heavy chain limits expression. In contrast, the poor expression of S107 could not be attributed to one of the chains in particular, since neither combination with 48G7 resulted in any appreciable increase in expression compared to S107 itself. In all other cases, the combinations showed expression levels somewhere in between those of the two partners. Based on these results, it is likely that the chimeric expression system will be suitable for the generation of expression libraries by cloning random combinations of V regions from the spleen of an immunized mouse without significant losses in diversity resulting from insufficient expression levels. Effects of Point Mutations on the Expression Level. Protein produced in this system has been used to solve the crystal structure of the recombinant Fab fragment of 48G7 to 2.0 A (P.A.P. and P.G.S., unpublished results). To better understand the mechanism of this antibody a series of amino acid substitutions around the active site was generated. Interestingly, although the use of rare codons was avoided in all cases, some of the mutations had large effects on the protein yield (Fig. 4) . According to their expression levels, the mutants fell into three classes. The Tyr33HHis, His35HAla, His35HGln, and His35HGlu mutants, Tyr -> Phe mutants at positions 99H and 100H, and the VK triple mutation GL48G7H (Asn3OLSer/Gly34LSer/ His55LAsp) all behaved like the wild-type 48G7. The Tyr9JLLys, Tyr94LAla, Arg96LAla, Arg96LLys, and TyrlOOHHis mutants showed 2-to 10-fold reductions in expression yields. In contrast to the Tyr99HPhe mutant, expression of the other three Tyr99H mutants was estimated to be at least 100-fold lower than that of wild-type 48G7 and comparable to the level of S107.
All mutations lie in the complementarity-determining region (CDR) loops or the X3-strands immediately behind a loop, and none of them affect buried residues. Changes from a Tyr to a hydrophilic or charged amino acid like His, Arg, or Lys occur in all three classes. Most notably, Tyr99H seems to accommodate no other change than the conservative replacement with Phe, even though it resides in a highly variable solvent-exposed position at the tip of the heavy chain CDR3 loop. Similar behavior is observed for the Phe and His mutants of the adjacent residue, TyrlOOH. Tyr9lL, Tyr94L, and Arg96L lie in the light chain CDR3 loop, and in the latter case, even the conservative change of Arg (which makes a hydrogen bond to the hapten) to Lys leads to a significant reduction in expression level. In contrast, significant changes can be made to Tyr-33H and His-35H in CDR1 of the heavy chain without significant effects (both residues contact the hapten). One possibility is that the E. coli translation machinery might be affected by small alterations in the mRNA, as observed by Duefias et al. (38) . Alternatively, amino acid substitutions in the loops could make the protein thermodynamically unstable, thereby rendering it susceptible to proteolytic attack. This phenomenon has also been reported by other groups (39, 40) . Alfthan et al. (41) have observed similar correlations of expression levels and protease sensitivity with temperature stability of Fab fragments that use different murine CHI regions. On the other hand, Knappik and Pluckthun (9) found positions in the heavy chain loops of the single-chain antibody McPC603 that influenced expression efficiency mainly through solubility effects without affecting the in vitro stability of the protein. The mutations in 48G7 seem to be of a different nature, however, since increased amounts of insoluble aggregates, as found by Knappik and Pluckthun (9), were not observed in our poorly expressing clones. It is possible that the human C regions, which are absent in Pluckthun's system, keep even unstable or partly unfolded V regions in solution, thus preventing aggregation and allowing proteases to remove the unfolded chains. It should be interesting to investigate whether the changes in expression titer in our system can indeed be correlated with protein stability.
Conclusion. We have demonstrated that a range of different hybridoma-derived antibodies and combinations of heavy and light chains not selected as pairs in vivo can be expressed as murine-human chimeric Fab fragments in E. coli. This expression system provides good yields of seven of eight antibodies assayed, and in each case the protein remained in soluble form. This chimeric system seems to be a viable compromise between the high expression levels of humanized antibodies and the low levels observed for murine Fab fragments, while avoiding the risk of losing catalytic activity by changing the V regions. Crystallography should be facilitated due to the greater homogeneity of the recombinant antibody when compared with murine Fab fragments generated by papain digestion, and site-directed mutagenesis becomes much less complicated, with the caveat of mutation effects on expression levels. Most importantly, however, attempts to improve the catalytic efficiency of existing antibodies by genetic approaches or the selection of catalytic clones from in vivo cDNA libraries (3, 4) should now become feasible.
